Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Terminated

Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer

Real-Time Evaluation of Severity of Perceived Pain in Patients With Cancer by Using Functional Near-Infrared Spectroscopy (fNIRS), and Investigation of Pain Relief Utilizing Virtual Reality Technologies

Outcome
Stopped earlyPI left (Other)
Phase
No phase (not a drug trial)
Status
Terminated
Study type
Interventional
Start
12 July 2022
Ended
10 April 2026
Enrollment
106 participants
Sites
1
Primary outcomes
Gain knowledge of Brain activity during pain
Sponsor type
Academic / other
Results posted
No
Last update
29 April 2026

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

This study aims to develop objective tools for assessing perceived pain severity in cancer patients and survivors, evaluate the sustained effectiveness of non-pharmacological interventions such as virtual reality in reducing pain and medication use, and create tools for the early detection of neuropathy. Wireless, non-invasive neuroimaging methods, including functional near-infrared spectroscopy (fNIRS), will be used to support these objectives

Detailed description public domain (ClinicalTrials.gov)

PRIMARY OBJECTIVES: I. Develop an algorithm for objective evaluation of pain severity and distinguish the location of pain without needing patient cooperation. II. Find the relationship between fNIRS (functional near-infrared spectroscopy) features and severity of pain as well as the relationship (if any) between perceived pain severity and psychological factors. III. Understand the acute cold dysesthesias with oxaliplatin and how this correlated with more chronic neuropathy IV. Investigate the sustained effects of therapeutic virtual reality versus Sham virtual reality on pain severity and medication doses. V. Monitor VR-induced changes of brain activity to find out the underlying mechanisms of pain alleviation. SECONDARY OBJECTIVES: I. Investigate the effect of demographic factors on perceived pain severity and VR-inducated pain alleviation \- Investigate the effects of repeated VR use on doses of medications. OUTLINE: Healthy participants are assigned to group A. Cancer patients are randomized to group B, C , D or E. GROUP A: Participants undergo fNIRS for 10 minutes. GROUP B: Patients undergo fNIRS for 10 minutes followed by a relaxation period using virtual reality (VR) for over 15 minutes. GROUP C: Patients undergo fNIRS for 10 minutes. GROUP D: Patients are randomized to 1 of 2 arm: ARM I - Patients use VR for up to 30 minutes. ARM II: Patients use Sham VR Program for up to 30 minutes GROUP E: Cold pack stimulation on Day 1 of each chemotherapy cycle and day 3.